Potential of Renin-Angiotensin-Aldosterone System Modulations in Diabetic Kidney Disease: Old Players to New Hope!
Author:
Publisher
Springer International Publishing
Link
https://link.springer.com/content/pdf/10.1007/112_2020_50
Reference162 articles.
1. Abuissa H, Jones PG, Marso SP, O’Keefe JH (2005) Angiotensin-converting enzyme inhibitors or angiotensin receptor blockers for prevention of type 2 diabetes: a meta-analysis of randomized clinical trials. J Am Coll Cardiol 46:821–826
2. Alicic RZ, Rooney MT, Tuttle KR (2017) Diabetic kidney disease: challenges, progress, and possibilities. Clin J Am Soc Nephrol 12:2032–2045
3. Anders HJ, Davis JM, Thurau K (2016) Nephron protection in diabetic kidney disease. N Engl J Med 375:2096–2098
4. Arora MK, Singh UK (2013) Molecular mechanisms in the pathogenesis of diabetic nephropathy: an update. Vascul Pharmacol 58:259–271
5. Athyros VG, Mikhailidis DP, Kakafika AI, Tziomalos K, Karagiannis A (2007) Angiotensin II reactivation and aldosterone escape phenomena in renin–angiotensin–aldosterone system blockade: is oral renin inhibition the solution? Expert Opin Pharmacother 8:529–535
Cited by 22 articles. 订阅此论文施引文献 订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献
1. Understanding the effects of COVID-19 on patients with diabetic nephropathy: a systematic review;Annals of Medicine & Surgery;2024-04-17
2. Molecular Targets of Novel Therapeutics for Diabetic Kidney Disease: A New Era of Nephroprotection;International Journal of Molecular Sciences;2024-04-03
3. Irbesartan ameliorates diabetic kidney injury in db/db mice by restoring circadian rhythm and cell cycle;Journal of Translational Internal Medicine;2024-04-01
4. Irbesartan ameliorates diabetic kidney injury in db/db mice by restoring circadian rhythm and cell cycle;Journal of Translational Internal Medicine;2024-04-01
5. Endothelial CXCR2 deficiency attenuates renal inflammation and glycocalyx shedding through NF-κB signaling in diabetic kidney disease;Cell Communication and Signaling;2024-03-25
1.学者识别学者识别
2.学术分析学术分析
3.人才评估人才评估
"同舟云学术"是以全球学者为主线，采集、加工和组织学术论文而形成的新型学术文献查询和分析系统，可以对全球学者进行文献检索和人才价值评估。用户可以通过关注某些学科领域的顶尖人物而持续追踪该领域的学科进展和研究前沿。经过近期的数据扩容，当前同舟云学术共收录了国内外主流学术期刊6万余种，收集的期刊论文及会议论文总量共计约1.5亿篇，并以每天添加12000余篇中外论文的速度递增。我们也可以为用户提供个性化、定制化的学者数据。欢迎来电咨询！咨询电话：010-8811{复制后删除}0370
www.globalauthorid.com
TOP
Copyright © 2019-2024 北京同舟云网络信息技术有限公司 京公网安备11010802033243号 京ICP备18003416号-3